{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:03:23Z","timestamp":1789592603056,"version":"build-2803163510"},"reference-count":263,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ecl.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T20:17:38Z","timestamp":1489868258000},"page":"335-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Genetic Aspects of Pituitary Adenomas"],"prefix":"10.1016","volume":"46","author":[{"given":"Pedro","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2014.11.004","article-title":"Pituitary tumors","volume":"44","author":"Melmed","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J\u00a0Neurooncol"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1227\/01.NEU.0000223437.51435.6E","article-title":"Pathobiology of pituitary adenomas and carcinomas","volume":"59","author":"Scheithauer","year":"2006","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an Endocrine Society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib6","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1530\/EJE-15-1272","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: pituitary \u201cincidentaloma\u201d: neuroradiological assessment and differential diagnosis","volume":"175","author":"Vasilev","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib7","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"223","key":"10.1016\/j.ecl.2017.01.004_bib9","first-page":"2172","article-title":"Epidemiology of pituitary adenoma: results of the first Swiss study","volume":"5","author":"Fontana","year":"2009","journal-title":"Rev Med Suisse"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and incidence of pituitary adenomas: a population based study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"issue":"9","key":"10.1016\/j.ecl.2017.01.004_bib11","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib12","doi-asserted-by":"crossref","first-page":"e82619","DOI":"10.1371\/journal.pone.0082619","article-title":"The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature","volume":"8","author":"Pease","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1677\/ERC-08-0167","article-title":"Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors","volume":"16","author":"Lin","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.ecl.2017.01.004_bib17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1590\/S0100-879X2012007500115","article-title":"Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas","volume":"45","author":"Murat","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.ecl.2017.01.004_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000345673","article-title":"Genetics of pituitary adenomas","volume":"41","author":"Gadelha","year":"2013","journal-title":"Front Horm Res"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2265.2002.01643.x","article-title":"Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours","volume":"57","author":"Kaltsas","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib21","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.ecl.2017.01.004_bib22","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"6236","key":"10.1016\/j.ecl.2017.01.004_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2015-4366","article-title":"Somatic GPR101 duplication causing X-linked acrogigantism (XLAG)-diagnosis and management","volume":"101","author":"Rodd","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"25","key":"10.1016\/j.ecl.2017.01.004_bib25","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib26","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2017.01.004_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib28","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/jcem-71-6-1427","article-title":"Clonal origin of pituitary adenomas","volume":"71","author":"Herman","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2017.01.004_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mce.2013.09.006","article-title":"Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma","volume":"386","author":"Zhou","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1172\/JCI114705","article-title":"Clinically nonfunctioning pituitary tumors are monoclonal in origin","volume":"86","author":"Alexander","year":"1990","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib31","first-page":"1303","article-title":"Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease","volume":"75","author":"Biller","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib32","first-page":"472","article-title":"Monoclonality of corticotroph macroadenomas in Cushing's disease","volume":"75","author":"Gicquel","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib33","first-page":"731","article-title":"Clonal origin of pituitary adenomas","volume":"73","author":"Jacoby","year":"1990","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/ERC-11-0059","article-title":"Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation","volume":"18","author":"Villa","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","article-title":"Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study","volume":"4","author":"Iacovazzo","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11102-005-3281-8","article-title":"Pituitary hyperplasia secondary to primary hypothyroidism: a case report and review of the literature","volume":"8","author":"Joshi","year":"2005","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cen.12960","article-title":"Phaeochromocytoma and ACTH-dependent Cushing's syndrome: tumor CRF-secretion can mimic pituitary Cushing's disease","volume":"84","author":"Lois","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1006390306336","article-title":"Molecular basis of pituitary oncogenesis","volume":"45","author":"Tada","year":"1999","journal-title":"J\u00a0Neurooncol"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2017.01.004_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000182498","article-title":"G-protein oncogenes in acromegaly","volume":"38","author":"Spada","year":"1992","journal-title":"Horm Res"},{"issue":"9","key":"10.1016\/j.ecl.2017.01.004_bib40","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/153537020322800904","article-title":"Genetics of pituitary tumors: focus on G-protein mutations","volume":"228","author":"Lania","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-15-1064","article-title":"Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas","volume":"174","author":"Ronchi","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib42","doi-asserted-by":"crossref","first-page":"M73","DOI":"10.1530\/EJE-15-0320","article-title":"Decoding the genetic basis of Cushing's disease: USP8 in the spotlight","volume":"173","author":"Theodoropoulou","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2017.01.004_bib43","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.e05-06-0560","article-title":"Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes","volume":"16","author":"Mizuno","year":"2005","journal-title":"Mol Biol Cell"},{"issue":"7","key":"10.1016\/j.ecl.2017.01.004_bib44","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease","volume":"100","author":"Perez-Rivas","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-15-0689","article-title":"The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease","volume":"174","author":"Hayashi","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1677\/ERC-09-0101","article-title":"Activation of RAF\/MEK\/ERK and PI3K\/AKT\/mTOR pathways in pituitary adenomas and their effects on downstream effectors","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2012.10.021","article-title":"Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes","volume":"92","author":"Orloff","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib48","first-page":"89","article-title":"ras mutations in human prolactinomas and pituitary carcinomas","volume":"78","author":"Cai","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib49","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jcem.74.4.1312542","article-title":"Ras mutations in human pituitary tumors","volume":"74","author":"Karga","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/hmg\/dds422","article-title":"Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas","volume":"22","author":"Kurelac","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.ecl.2017.01.004_bib51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.5858\/2004-128-776-OTIPAI","article-title":"Oncocytic transformation in pituitary adenomas: immunohistochemical analyses of 65 cases","volume":"128","author":"Niveiro","year":"2004","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib52","first-page":"1562","article-title":"Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome","volume":"124","author":"Hao","year":"2016","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11102-016-0720-7","article-title":"A\u00a0high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas","volume":"19","author":"Casar-Borota","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2017.01.004_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pathol.4.110807.092259","article-title":"The pathogenesis of pituitary tumors","volume":"4","author":"Asa","year":"2009","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib55","first-page":"43","article-title":"EMT involved in migration of stem\/progenitor cells for pituitary development and regeneration","volume":"5","author":"Yoshida","year":"2016","journal-title":"J\u00a0Clin Med"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib56","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1210\/jc.2015-4191","article-title":"Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas","volume":"101","author":"Cannavo","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/EJE-10-0465","article-title":"Increased prevalence of acromegaly in a highly polluted area","volume":"163","author":"Cannavo","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10528-015-9709-6","article-title":"Molecular mechanisms underlying pituitary pathogenesis","volume":"54","author":"Sapochnik","year":"2016","journal-title":"Biochem Genet"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib59","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/eje.0.143r001","article-title":"Cyclin D and cyclin E expression in normal and adenomatous pituitary","volume":"143","author":"Jordan","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"22","key":"10.1016\/j.ecl.2017.01.004_bib60","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1158\/0008-5472.CAN-05-0884","article-title":"Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses","volume":"65","author":"Moreno","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib61","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.beem.2010.03.001","article-title":"The genetics of pituitary adenomas","volume":"24","author":"Vandeva","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/JME-08-0146","article-title":"Cell cycle control of pituitary development and disease","volume":"42","author":"Quereda","year":"2009","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"18","key":"10.1016\/j.ecl.2017.01.004_bib63","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1101\/gad.12.18.2899","article-title":"CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis","volume":"12","author":"Franklin","year":"1998","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib64","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1530\/eje.0.1400250","article-title":"Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas","volume":"140","author":"Bamberger","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jnen\/64.5.398","article-title":"The p15(INK4b)\/p16(INK4a)\/RB1 pathway is frequently deregulated in human pituitary adenomas","volume":"64","author":"Ogino","year":"2005","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib66","first-page":"1211","article-title":"Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island","volume":"60","author":"Simpson","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib67","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/carcin\/22.8.1149","article-title":"Aberrant expression of G(1)\/S regulators is a frequent event in sporadic pituitary adenomas","volume":"22","author":"Simpson","year":"2001","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib68","first-page":"2133","article-title":"Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors","volume":"5","author":"Hibberts","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1385\/EP:12:1:39","article-title":"Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas","volume":"12","author":"Saeger","year":"2001","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib70","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/mend.11.4.9911","article-title":"Isolation and characterization of a pituitary tumor-transforming gene (PTTG)","volume":"11","author":"Pei","year":"1997","journal-title":"Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib71","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1677\/ERC-08-0012","article-title":"Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update","volume":"15","author":"Salehi","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/er.2006-0042","article-title":"Pituitary tumor-transforming gene: physiology and implications for tumorigenesis","volume":"28","author":"Vlotides","year":"2007","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib73","doi-asserted-by":"crossref","first-page":"e90396","DOI":"10.1371\/journal.pone.0090396","article-title":"Correlations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.ecl.2017.01.004_bib74","first-page":"6794","article-title":"The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas","volume":"60","author":"Pagotto","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib75","first-page":"1262","article-title":"Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis","volume":"87","author":"Zhang","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2017.01.004_bib76","doi-asserted-by":"crossref","first-page":"e77406","DOI":"10.1371\/journal.pone.0077406","article-title":"ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas","volume":"8","author":"Neto","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ecl.2017.01.004_bib77","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1210\/jc.2007-2633","article-title":"Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3\/DLK1 locus in human clinically nonfunctioning pituitary adenomas","volume":"93","author":"Gejman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.ecl.2017.01.004_bib78","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1073\/pnas.90.17.7961","article-title":"Nerve growth factor suppresses the transforming phenotype of human prolactinomas","volume":"90","author":"Missale","year":"1993","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib79","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1210\/en.2006-0905","article-title":"Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion","volume":"148","author":"Shorts-Cary","year":"2007","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1677\/joe.1.05616","article-title":"Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells","volume":"183","author":"Theodoropoulou","year":"2004","journal-title":"J\u00a0Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib81","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1677\/joe.0.1530131","article-title":"Analysis of a protein kinase C-alpha mutation in human pituitary tumours","volume":"153","author":"Schiemann","year":"1997","journal-title":"J\u00a0Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/ERC-11-0135","article-title":"PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis","volume":"19","author":"Palmieri","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib83","first-page":"189","article-title":"Pit-1 gene expression in the human pituitary and pituitary adenomas","volume":"79","author":"Pellegrini","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib84","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2006.04.024","article-title":"HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity","volume":"9","author":"Fedele","year":"2006","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib85","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1210\/en.2007-0542","article-title":"Wnt pathway inhibitors are strongly down-regulated in pituitary tumors","volume":"149","author":"Elston","year":"2008","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11102-008-0147-x","article-title":"Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis","volume":"12","author":"Gueorguiev","year":"2009","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.ecl.2017.01.004_bib87","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.18632\/oncotarget.7279","article-title":"Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib88","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1210\/jc.2011-2031","article-title":"Clinical review: pituitary carcinoma: difficult diagnosis and treatment","volume":"96","author":"Heaney","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2017.01.004_bib89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000318489","article-title":"Molecular mechanisms of pituitary adenoma senescence","volume":"38","author":"Chesnokova","year":"2010","journal-title":"Front Horm Res"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2017.01.004_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2010.02.012","article-title":"Pituitary senescence: the evolving role of Pttg","volume":"326","author":"Chesnokova","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12022-015-9405-4","article-title":"Oncogene-induced senescence in pituitary adenomas-an immunohistochemical Study","volume":"27","author":"Manojlovic-Gacic","year":"2016","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.14310\/horm.2002.1358","article-title":"Oncogene-induced senescence in pituitary adenomas and carcinomas","volume":"11","author":"Alexandraki","year":"2012","journal-title":"Hormones (Athens)"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib93","doi-asserted-by":"crossref","first-page":"e17924","DOI":"10.1371\/journal.pone.0017924","article-title":"Lineage-specific restraint of pituitary gonadotroph cell adenoma growth","volume":"6","author":"Chesnokova","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ecl.2017.01.004_bib94","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/BF03346759","article-title":"MicroRNAs: suggested role in pituitary adenoma pathogenesis","volume":"36","author":"Gadelha","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib95","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1227\/NEU.0000000000000369","article-title":"MicroRNAs as biomarkers in pituitary tumors","volume":"75","author":"Di Ieva","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ecl.2017.01.004_bib96","doi-asserted-by":"crossref","first-page":"435171","DOI":"10.1155\/2014\/435171","article-title":"MicroRNAs in human pituitary adenomas","volume":"2014","author":"Li","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib97","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12022-011-9167-6","article-title":"MicroRNAs in the human pituitary","volume":"22","author":"Sivapragasam","year":"2011","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib98","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jcp.20282","article-title":"miR-15a and miR-16-1 down-regulation in pituitary adenomas","volume":"204","author":"Bottoni","year":"2005","journal-title":"J\u00a0Cell Physiol"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2017.01.004_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2014.03.002","article-title":"Mir-23b and miR-130b expression is downregulated in pituitary adenomas","volume":"390","author":"Leone","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"2 Pt B","key":"10.1016\/j.ecl.2017.01.004_bib100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.canlet.2014.10.003","article-title":"MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5","volume":"356","author":"Renjie","year":"2015","journal-title":"Cancer Lett"},{"issue":"16","key":"10.1016\/j.ecl.2017.01.004_bib101","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1080\/15384101.2015.1064207","article-title":"Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors","volume":"14","author":"Mussnich","year":"2015","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.ecl.2017.01.004_bib102","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1210\/jc.2010-0581","article-title":"Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas","volume":"95","author":"Butz","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib103","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1152\/ajpendo.00546.2011","article-title":"MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in\u00a0vitro","volume":"303","author":"Trivellin","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ecl.2017.01.004_bib104","first-page":"54","article-title":"Deregulation of miR-183 and KIAA0101 in aggressive and malignant pituitary tumors","volume":"2","author":"Roche","year":"2015","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.ecl.2017.01.004_bib105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1746-1596-5-79","article-title":"Differential expression of microRNAs in GH-secreting pituitary adenomas","volume":"5","author":"Mao","year":"2010","journal-title":"Diagn Pathol"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib106","first-page":"1312","article-title":"microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment","volume":"27","author":"Wang","year":"2012","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ecl.2014.10.002","article-title":"Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"44","author":"Daly","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib108","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.ecl.2017.01.004_bib109","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers","volume":"100","author":"Hernandez-Ramirez","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5777","key":"10.1016\/j.ecl.2017.01.004_bib110","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib111","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12020-013-0125-6","article-title":"The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas","volume":"46","author":"Lloyd","year":"2014","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/EJE-11-0304","article-title":"High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas","volume":"165","author":"Tichomirowa","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib113","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/JOE-11-0054","article-title":"AIP and its interacting partners","volume":"210","author":"Trivellin","year":"2011","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ecl.2017.01.004_bib114","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","article-title":"The aryl hydrocarbon receptor: multitasking in the immune system","volume":"32","author":"Stockinger","year":"2014","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib115","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2353\/ajpath.2009.081131","article-title":"The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas","volume":"175","author":"Heliovaara","year":"2009","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib116","doi-asserted-by":"crossref","first-page":"E1411","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib117","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1677\/ERC-09-0094","article-title":"Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications","volume":"16","author":"Jaffrain-Rea","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib118","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2016-1307","article-title":"Rapid proteasomal degradation of mutant proteins is the primary mechanism leading to tumorigenesis in patients with missense AIP mutations","volume":"101","author":"Hernandez-Ramirez","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib119","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/mol.104.008888","article-title":"The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse","volume":"67","author":"Lahvis","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib120","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1124\/mol.108.047068","article-title":"A\u00a0hypomorphic allele of aryl hydrocarbon receptor-associated protein-9 produces a phenocopy of the AHR-null mouse","volume":"74","author":"Lin","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/taap.1996.0210","article-title":"Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity","volume":"140","author":"Fernandez-Salguero","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib122","first-page":"1194","article-title":"The aryl hydrocarbon receptor: studies using the AHR-null mice","volume":"26","author":"Gonzalez","year":"1998","journal-title":"Drug Metab Dispos"},{"issue":"2\u20133","key":"10.1016\/j.ecl.2017.01.004_bib123","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tox.2008.01.002","article-title":"Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors","volume":"246","author":"Peng","year":"2008","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib124","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/mol.109.059675","article-title":"Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4","volume":"77","author":"Barhoover","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.21292","article-title":"Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families","volume":"31","author":"Igreja","year":"2010","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.ecl.2017.01.004_bib126","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/onc.2014.50","article-title":"AIP inactivation leads to pituitary tumorigenesis through defective G\u03b1i-cAMP signaling","volume":"34","author":"Tuominen","year":"2015","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.ecl.2017.01.004_bib127","doi-asserted-by":"crossref","first-page":"13791","DOI":"10.1073\/pnas.2434345100","article-title":"Regulation of survivin function by Hsp90","volume":"100","author":"Fortugno","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"34","key":"10.1016\/j.ecl.2017.01.004_bib128","doi-asserted-by":"crossref","first-page":"24721","DOI":"10.1074\/jbc.M603175200","article-title":"Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein","volume":"281","author":"Kang","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib129","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/sj.emboj.7601636","article-title":"The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1\/p53 pathway, preventing tumor growth","volume":"26","author":"Canibano","year":"2007","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1008020","article-title":"AIP mutation in pituitary adenomas in the 18th century and today","volume":"364","author":"Chahal","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2017.01.004_bib131","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/humu.23121","article-title":"Increased population risk of AIP-related acromegaly and gigantism in Ireland","volume":"38","author":"Radian","year":"2017","journal-title":"Human Mutation"},{"issue":"Suppl","key":"10.1016\/j.ecl.2017.01.004_bib132","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11102-012-0391-y","article-title":"Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor","volume":"15","author":"Guaraldi","year":"2012","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib133","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S1807-59322010000400010","article-title":"Isolated familial somatotropinoma: 11q13-loh and gene\/protein expression analysis suggests a possible involvement of AIP also in non-pituitary tumorigenesis","volume":"65","author":"Toledo","year":"2010","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib134","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2006-2513","article-title":"Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families","volume":"92","author":"Daly","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1530\/EJE-09-0406","article-title":"Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene","volume":"161","author":"Jennings","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2017.01.004_bib136","unstructured":"Korbonits M, Dutta P, Reddy KS, et al. Exome sequencing reveals double hit by AIP gene mutation and copy loss of chromosome 11 but negative X-LAG in a pituitary adenoma of a 4 years child with gigantism treated with multimodal therapy. Paper presented at the Endocrine Society. Boston, April 2, 2016. Available at: https:\/\/endo.confex.com\/endo\/2016endo\/webprogram\/Paper28082.html."},{"issue":"11","key":"10.1016\/j.ecl.2017.01.004_bib137","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/BF03350345","article-title":"The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: mutational hot-spot or founder effect?","volume":"33","author":"Occhi","year":"2010","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib138","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib139","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1677\/ERC-08-0287","article-title":"Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma","volume":"16","author":"Khoo","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-15-1044","article-title":"Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas","volume":"174","author":"Lecoq","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2017.01.004_bib141","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study","volume":"95","author":"Daly","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib142","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-07-0348","article-title":"The clinical, pathological, and genetic features of familial isolated pituitary adenomas","volume":"157","author":"Beckers","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib143","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients","volume":"22","author":"Rostomyan","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib144","doi-asserted-by":"crossref","first-page":"L11","DOI":"10.1530\/ERC-13-0218","article-title":"Familial pituitary apoplexy as the only presentation of a novel AIP mutation","volume":"20","author":"Xekouki","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53","volume":"94","author":"Kasuki","year":"2011","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib146","doi-asserted-by":"crossref","first-page":"L25","DOI":"10.1530\/ERC-12-0020","article-title":"AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression","volume":"19","author":"Kasuki","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib147","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1530\/ERC-12-0322","article-title":"Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations","volume":"20","author":"Jaffrain-Rea","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib148","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tem.2012.11.007","article-title":"Novel pathway for somatostatin analogs in patients with acromegaly","volume":"24","author":"Gadelha","year":"2013","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib149","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/EJE-15-0832","article-title":"Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study","volume":"174","author":"Iacovazzo","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.2012.04445.x","article-title":"Familial pituitary adenomas\u2014who should be tested for AIP mutations?","volume":"77","author":"Korbonits","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib151","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2013-2868","article-title":"Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation","volume":"99","author":"Williams","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib152","doi-asserted-by":"crossref","first-page":"E2789","DOI":"10.1210\/jc.2014-2094","article-title":"Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study","volume":"99","author":"Schofl","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib153","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/ERC-15-0038","article-title":"X-linked acrogigantism syndrome: clinical profile and therapeutic responses","volume":"22","author":"Beckers","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib154","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/ERC-16-0082","article-title":"Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1530\/ERC-16-0091","article-title":"Screening for GPR101 defects in pediatric pituitary corticotropinomas","volume":"23","author":"Trivellin","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib156","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JME-13-0172","article-title":"cAMP in the pituitary: an old messenger for multiple signals","volume":"52","author":"Peverelli","year":"2014","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib157","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/ERC-15-0478","article-title":"GHRH excess and blockade in X-LAG syndrome","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib158","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM199008023230507","article-title":"Gigantism due to pituitary mammosomatotroph hyperplasia","volume":"323","author":"Moran","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib159","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0042-100733","article-title":"GPR101 mutations are not a frequent cause of congenital isolated growth hormone deficiency","volume":"48","author":"Castinetti","year":"2016","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12020-015-0804-6","article-title":"Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome","volume":"51","author":"Naves","year":"2016","journal-title":"Endocrine"},{"issue":"7412","key":"10.1016\/j.ecl.2017.01.004_bib161","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature11396","article-title":"Rate of de novo mutations and the importance of father's age to disease risk","volume":"488","author":"Kong","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib162","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000371819","article-title":"MEN1, MEN4, and Carney complex: pathology and molecular genetics","volume":"103","author":"Schernthaner-Reiter","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"9","key":"10.1016\/j.ecl.2017.01.004_bib163","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5311","key":"10.1016\/j.ecl.2017.01.004_bib164","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ecl.2017.01.004_bib165","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib166","doi-asserted-by":"crossref","first-page":"e39767","DOI":"10.1371\/journal.pone.0039767","article-title":"The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the \u201cKnudson\u2019s second hit\u201d","volume":"7","author":"Luzi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib167","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib168","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J\u00a0Intern Med"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib169","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1677\/erc.1.01294","article-title":"Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis","volume":"13","author":"Fontaniere","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.ecl.2017.01.004_bib170","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1210\/en.2004-0124","article-title":"Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2","volume":"145","author":"La","year":"2004","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib171","first-page":"333","article-title":"Role of menin in the regulation of telomerase activity in normal and cancer cells","volume":"33","author":"Hashimoto","year":"2008","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib172","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib173","first-page":"726","article-title":"Menin represses tumorigenesis via repressing cell proliferation","volume":"1","author":"Wu","year":"2011","journal-title":"Am J Cancer Res"},{"issue":"7","key":"10.1016\/j.ecl.2017.01.004_bib174","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/onc.2014.3","article-title":"MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2","volume":"34","author":"Gillam","year":"2015","journal-title":"Oncogene"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2017.01.004_bib175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib176","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib177","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2265.2002.01505.x","article-title":"Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions","volume":"56","author":"Cavaco","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib178","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1086\/301729","article-title":"Characterization of mutations in patients with multiple endocrine neoplasia type 1","volume":"62","author":"Bassett","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib179","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1530\/EJE-15-0691","article-title":"Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'etude des Tumeurs Endocrines study","volume":"173","author":"Thevenon","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2017.01.004_bib180","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddt039","article-title":"Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study","volume":"22","author":"Thevenon","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib181","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/EJE-15-0879","article-title":"Polymorphisms in MEN1 and DRD2 genes are associated with the occurrence and characteristics of pituitary adenomas","volume":"175","author":"Peculis","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.ecl.2017.01.004_bib182","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib183","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib184","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verges","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib186","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","article-title":"Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database","volume":"76","author":"Sakurai","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib187","first-page":"4776","article-title":"Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib188","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/(SICI)1098-2744(199810)23:2<96::AID-MC6>3.0.CO;2-#","article-title":"Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption","volume":"23","author":"Shull","year":"1998","journal-title":"Mol Carcinog"},{"issue":"Suppl 3","key":"10.1016\/j.ecl.2017.01.004_bib189","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4158\/EP10379.RA","article-title":"Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice","volume":"17","author":"Newey","year":"2011","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13633-015-0011-5","article-title":"Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1","volume":"2015","author":"Gan","year":"2015","journal-title":"Int J Pediatr Endocrinol"},{"issue":"42","key":"10.1016\/j.ecl.2017.01.004_bib191","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib192","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2265.2008.03379.x","article-title":"Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations","volume":"70","author":"Igreja","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib193","doi-asserted-by":"crossref","first-page":"e1003350","DOI":"10.1371\/journal.pgen.1003350","article-title":"A\u00a0novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype","volume":"9","author":"Occhi","year":"2013","journal-title":"PLoS Genet"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib194","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib195","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/MCB.02171-06","article-title":"Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity","volume":"28","author":"James","year":"2008","journal-title":"Mol Cell Biol."},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib196","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/0008-5472.CAN-04-1357","article-title":"BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells","volume":"65","author":"Andreu","year":"2005","journal-title":"Cancer Res"},{"issue":"44","key":"10.1016\/j.ecl.2017.01.004_bib197","doi-asserted-by":"crossref","first-page":"40888","DOI":"10.1074\/jbc.M106448200","article-title":"Constitutive MEK\/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells","volume":"276","author":"Donovan","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ecl.2017.01.004_bib198","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-213934","article-title":"Uncommon association of cerebral meningioma, parathyroid adenoma and papillary thyroid carcinoma in a patient harbouring a rare germline variant in the CDKN1B gene","author":"Bugalho","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib199","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-11-0929","article-title":"Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype","volume":"166","author":"Malanga","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2017.01.004_bib200","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A\u00a0novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat"},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib201","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/ERC-11-0362","article-title":"Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds","volume":"19","author":"Tichomirowa","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib203","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ecl.2017.01.004_bib204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-1-21","article-title":"Carney complex (CNC)","volume":"1","author":"Bertherat","year":"2006","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib205","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03343875","article-title":"Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes","volume":"24","author":"Stratakis","year":"2001","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"9","key":"10.1016\/j.ecl.2017.01.004_bib206","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"20","key":"10.1016\/j.ecl.2017.01.004_bib207","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/hmg\/9.20.3037","article-title":"Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex","volume":"9","author":"Kirschner","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: an update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib209","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib210","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ecl.2017.01.004_bib211","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/1078-0432.CCR-07-1155","article-title":"Large deletions of the PRKAR1A gene in Carney complex","volume":"14","author":"Horvath","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.ecl.2017.01.004_bib212","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1158\/0008-5472.CAN-09-1601","article-title":"Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells","volume":"69","author":"Ragazzon","year":"2009","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.ecl.2017.01.004_bib213","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/ddg160","article-title":"Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1\/2","volume":"12","author":"Robinson-White","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"21","key":"10.1016\/j.ecl.2017.01.004_bib214","doi-asserted-by":"crossref","first-page":"10603","DOI":"10.1158\/0008-5472.CAN-06-2200","article-title":"PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes","volume":"66","author":"Robinson-White","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/humu.21178","article-title":"Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update","volume":"31","author":"Horvath","year":"2010","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib216","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1210\/jc.2013-3159","article-title":"Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing","volume":"99","author":"Salpea","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2017.01.004_bib217","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2013.08.022","article-title":"Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics","volume":"386","author":"Salpea","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib218","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jmg.40.4.268","article-title":"Chromosome 2 (2p16) abnormalities in Carney complex tumours","volume":"40","author":"Matyakhina","year":"2003","journal-title":"J\u00a0Med Genet"},{"issue":"11","key":"10.1016\/j.ecl.2017.01.004_bib219","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMc1309730","article-title":"PRKACB and Carney complex","volume":"370","author":"Forlino","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib220","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2005-2708","article-title":"A\u00a0PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds","volume":"91","author":"Groussin","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib221","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/jc.2010-1704","article-title":"Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype","volume":"96","author":"Libe","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib222","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CCO.0b013e32801195eb","article-title":"Carney complex: the first 20 years","volume":"19","author":"Boikos","year":"2007","journal-title":"Curr Opin Oncol"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2017.01.004_bib223","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2010.04.027","article-title":"PRKAR1A and the evolution of pituitary tumors","volume":"326","author":"Kirschner","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib224","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-006-0265-2","article-title":"Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities","volume":"9","author":"Boikos","year":"2006","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13244-012-0208-6","article-title":"The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation","volume":"4","author":"Courcoutsakis","year":"2013","journal-title":"Insights Imaging"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib226","first-page":"413","article-title":"Neurosurgical implications of Carney complex","volume":"92","author":"Watson","year":"2000","journal-title":"J\u00a0Neurosurg"},{"issue":"10","key":"10.1016\/j.ecl.2017.01.004_bib227","first-page":"3860","article-title":"Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the \u201dcomplex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas\u201c (Carney complex)","volume":"85","author":"Pack","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2017.01.004_bib228","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000079049","article-title":"Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex)","volume":"32","author":"Stratakis","year":"2004","journal-title":"Front Horm Res"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib229","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-14-0545","article-title":"Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas","volume":"171","author":"Larkin","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0954-6820.1952.tb13837.x","article-title":"Acromegaly associated with phaeochromocytoma","volume":"142","author":"Iversen","year":"1952","journal-title":"Acta Med Scand"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib231","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib232","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2265.2008.03368.x","article-title":"SDHC mutation in an elderly patient without familial antecedents","volume":"69","author":"Lopez-Jimenez","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib233","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"Denes","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-13-0623","article-title":"Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis","volume":"170","author":"Papathomas","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib235","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1210\/jc.2011-1179","article-title":"Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?","volume":"97","author":"Xekouki","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib236","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1210\/jc.2014-4297","article-title":"Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice","volume":"100","author":"Xekouki","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib237","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1530\/ERC-15-0241","article-title":"15 YEARS OF PARAGANGLIOMA: the association of pituitary adenomas and phaeochromocytomas or paragangliomas","volume":"22","author":"O'Toole","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib238","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s11102-015-0672-3","article-title":"Cushing's disease and co-existing phaeochromocytoma","volume":"19","author":"Johnston","year":"2016","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib239","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/RLU.0000000000000235","article-title":"SPECT and 18F-FDG PET\/CT imaging of multiple paragangliomas and a growth hormone-producing pituitary adenoma as phenotypes from a novel succinate dehydrogenase subunit D mutation","volume":"39","author":"Skoura","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0031-1301302","article-title":"An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes","volume":"44","author":"Gimenez-Roqueplo","year":"2012","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.ecl.2017.01.004_bib241","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ecl.2017.01.004_bib242","first-page":"P239","article-title":"Familial prolactinoma occurring in association with SDHB mutation positive paraganglioma","volume":"19","author":"Brahma","year":"2009","journal-title":"Endocr Abstr Spring"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib243","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ecl.2017.01.004_bib244","first-page":"732452","article-title":"Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma","volume":"2011","author":"Heinlen","year":"2011","journal-title":"ISRN Oncol"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib245","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cen.12072","article-title":"Confusing genes: a patient with MEN2A and Cushing's disease","volume":"78","author":"Naziat","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib246","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-008-0388-9","article-title":"Pituitary blastoma","volume":"116","author":"Scheithauer","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.ecl.2017.01.004_bib247","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11102-011-0328-x","article-title":"Pituitary blastoma: a unique embryonal tumor","volume":"15","author":"Scheithauer","year":"2012","journal-title":"Pituitary"},{"issue":"03_MeetingAbstracts","key":"10.1016\/j.ecl.2017.01.004_bib248","first-page":"P1","article-title":"New phenotype in the familial DICER1 tumor syndrome: pituitary blastoma presenting at age 9\u00a0months","volume":"32","author":"Wildi-Runge","year":"2011","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.ecl.2017.01.004_bib249","doi-asserted-by":"crossref","first-page":"E1487","DOI":"10.1210\/jc.2014-1016","article-title":"Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease","volume":"99","author":"Sahakitrungruang","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib250","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2010.081216","article-title":"Germline DICER1 mutations and familial cystic nephroma","volume":"47","author":"Bahubeshi","year":"2010","journal-title":"J\u00a0Med Genet"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib251","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/humu.21600","article-title":"Extending the phenotypes associated with DICER1 mutations","volume":"32","author":"Foulkes","year":"2011","journal-title":"Hum Mutat"},{"issue":"5943","key":"10.1016\/j.ecl.2017.01.004_bib252","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.1174334","article-title":"DICER1 mutations in familial pleuropulmonary blastoma","volume":"325","author":"Hill","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ecl.2017.01.004_bib253","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-3-12","article-title":"McCune-Albright syndrome","volume":"3","author":"Dumitrescu","year":"2008","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2017.01.004_bib254","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1750-1172-7-S1-S4","article-title":"McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia","volume":"7","author":"Collins","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib255","first-page":"675","article-title":"Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting","volume":"22","author":"Weinstein","year":"2001","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ecl.2017.01.004_bib256","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1210\/jc.2003-031225","article-title":"Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome\u2013a European Collaborative Study","volume":"89","author":"Lumbroso","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2017.01.004_bib257","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0004.1986.tb01261.x","article-title":"The McCune-Albright syndrome: a lethal gene surviving by mosaicism","volume":"29","author":"Happle","year":"1986","journal-title":"Clin Genet"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib258","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1210\/en.2004-0865","article-title":"Minireview: GNAS: normal and abnormal functions","volume":"145","author":"Weinstein","year":"2004","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib259","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1172\/JCI11887","article-title":"Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly","volume":"107","author":"Hayward","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.ecl.2017.01.004_bib260","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1210\/jc.2001-012022","article-title":"Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome","volume":"87","author":"Akintoye","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2017.01.004_bib261","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1210\/jc.2012-1274","article-title":"Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome","volume":"97","author":"Vortmeyer","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2017.01.004_bib262","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2013-3826","article-title":"Acromegaly and McCune-Albright syndrome","volume":"99","author":"Salenave","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2017.01.004_bib263","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2006-0561","article-title":"McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and\/or pegvisomant in somatostatin analog-resistant patients","volume":"91","author":"Galland","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985291730004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985291730004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:43:18Z","timestamp":1760175798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985291730004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":263,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S088985291730004X"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2017.01.004","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Aspects of Pituitary Adenomas","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}